4 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 4 |
| Phase 2 | 1 | Recruiting 1 |
Follow Keratoconus: new trials by email Literature Review of Keratoconus trials Research Report on Keratoconus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia Riboflavin 0.1% ophthalmic solution and pulsed light, Riboflavin 0.1% ophthalmic solution and non-pulsed light - Keratoconus, Corneal Ectasia | Phase 2 / Phase 3 | Recruiting | Price Vision Group | 500 | 2025-10-01 | 2026-09-25 |
| Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases Epi-ON corneal cross-linking - Keratoconus, Ectasia of Cornea | Phase 3 | Recruiting | Woolfson Eye Institute | 485 | 2025-08-01 | 2026-02-02 |
| Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome Epi-ON corneal cross-linking (CXL) - Down Syndrome (DS), Keratoconus | Phase 3 | Recruiting | Woolfson Eye Institute | 225 | 2025-08-01 | 2026-02-02 |
| Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus Insulin, Placebo eye drops of 0.5% Methylcellulose - Keratoconus, Cornea Disease | Phase 3 | Recruiting | University of Campinas, Brazil | 36 | 2024-08-01 | 2025-01-14 |
Corneal Diseases (2) · Down Syndrome (1) · Eye Diseases (1)
Eye Diseases (3) · Corneal Diseases (2) · Abnormalities, Multiple (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Intellectual Disability (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1)
Corneal Cross-Linking (2) · Insulin (1) · Methylcellulose (1) · Ophthalmic Solutions (1) · Riboflavin (1)
Woolfson Eye Institute (2) · Price Vision Group (1) · University of Campinas, Brazil (1)
United States (3) · Brazil (1)
Francis Price, MD (1) · Monica Alves, PhD (1)